RNAi-mediated inhibition of tumor necrosis factor alpha-related conditions

Details for Australian Patent Application No. 2007253776 (hide)

Owner Alcon Research, Ltd.

Inventors Senchyna, Diane Michelle; Gamache, Daniel A.; Chatterton, Jon E.; Miller, Steven T.; Yanni, John M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007253776

PCT Pub. Number WO2007/137129

Priority 60/801,788 19.05.06 US

Filing date 17 May 2007

Wipo publication date 29 November 2007

Acceptance publication date 26 April 2012

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/137129 Priority application(s): WO2007/137129

26 April 2012 Application Accepted

  Published as AU-B-2007253776

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007253790-Process for treating a gas stream

2007253775-Glyceryl and glycol acid compounds